TCL Archive Mendelsohn Defends ImClone’s Actions And His Role In Development of C225 October 18, 2002
TCL Archive NCA Asks HHS To Exempt From DRG Peer Reviewed Institutions With At Least 25 Protocol Patients August 12, 1983
TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006